[RGLS] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
19-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -118.74%
YoY- -444.02%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Revenue 18 204 1,865 1,083 6,118 2,809 3,809 -59.00%
PBT -15,835 -19,515 -13,016 -9,798 -2,169 -5,691 -1,041 57.34%
Tax -7 4 -16 -2,259 -5 -6 4 -
NP -15,828 -19,519 -13,000 -9,798 -2,164 -5,685 -1,045 57.23%
Tax Rate - - - - - - - -
Total Cost 15,846 19,723 14,865 10,881 8,282 8,494 4,854 21.77%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
NP Margin -87,933.33 -9,568.14 -697.05 -904.71 -35.37 -202.39 -27.44 283.49%
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
EPS -21.09 -44.33 -30.01 -27.09 -6.47 -1,918.02 -352.56 -37.43%
EPS Diluted -21.09 -44.33 -30.01 -26.21 -6.25 -1,918.02 -352.56 -37.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.